Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « AbsEn.i » - entrée « inhibitors »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
inhibitor < inhibitors < inhibitory  Facettes :

List of bibliographic references indexed by inhibitors

Number of relevant bibliographic references: 118.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000009 (2021) Rashed Noor [Bangladesh]Antiviral drugs against severe acute respiratory syndrome coronavirus 2 infection triggering the coronavirus disease-19 pandemic.
000021 (2021) Pierre Ekobena [Suisse] ; Anton Ivanyuk [Suisse] ; Françoise Livio [Suisse][Pharmacovigilance update].
000038 (2021) María Antonela Zígolo [Argentine] ; Matías Rivero Goytia [Argentine] ; Hugo Ramiro Poma [Argentine] ; Ver Nica Beatriz Rajal [Singapour] ; Ver Nica Patricia Irazusta [Argentine]Virtual screening of plant-derived compounds against SARS-CoV-2 viral proteins using computational tools.
000130 (2021) Yudibeth Sixto-L Pez [Mexique] ; José Correa-Basurto [Mexique] ; Martiniano Bello [Mexique] ; Bruno Landeros-Rivera [France] ; Jose Antonio Garz N-Tiznado [Mexique] ; Sarita Monta O [Mexique]Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population.
000137 (2021) Ça La Begüm Apayd N [Turquie] ; Gözde Ç Nar [Turquie] ; Gökçe Cihan-Üstünda [Turquie]Small-molecule antiviral agents in ongoing clinical trials for COVID-19.
000166 (2021) Giulia Fiscon [Italie] ; Federica Conte [Italie] ; Lorenzo Farina [Italie] ; Paola Paci [Italie]SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
000174 (2021) Abdo A. Elfiky [Égypte]SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective.
000203 (2021) F O Shode [Afrique du Sud] ; A S K. Idowu [Afrique du Sud] ; O J Uhomoibhi [Afrique du Sud] ; S. Sabiu [Afrique du Sud]Repurposing drugs and identification of inhibitors of integral proteins (spike protein and main protease) of SARS-CoV-2.
000236 (2021) Hui Moon Koh [Malaisie] ; Pei Feng Chong [Malaisie] ; Ju Nee Tan [Malaisie] ; Suresh Kumar Chidambaram [Malaisie] ; Hiu Jian Chua [Malaisie]QT prolongation associated with hydroxychloroquine and protease inhibitors in COVID-19.
000263 (2021) Fouzia Mesli [Algérie] ; Meriem Ghalem [Algérie] ; Ismail Daoud [Algérie] ; Said Ghalem [Algérie]Potential inhibitors of angiotensin converting enzyme 2 receptor of COVID-19 by Corchorus olitorius Linn using docking, molecular dynamics, conceptual DFT investigation and pharmacophore mapping.
000264 (2021) Yanqiang Han ; Zhilong Wang ; Jiahao Ren ; Zhiyun Wei ; Jinjin Li [République populaire de Chine]Potential inhibitors for the novel coronavirus (SARS-CoV-2).
000277 (2021) Gustavo José Da Silva Pereira [Brésil] ; Anderson Henrique França Figueredo Leão [Brésil] ; Adolfo Garcia Erustes [Brésil] ; Ingrid Beatriz De Melo Morais [Brésil] ; Talita Aparecida De Moraes Vrechi [Brésil] ; Lucas Dos Santos Zamarioli [Brésil] ; Cássia Arruda Souza Pereira [Brésil] ; Laís De Oliveira Marchioro [Brésil] ; Letícia Paulino Sperandio [Brésil] ; Ísis Valeska Freire Lins [Brésil] ; Mauro Piacentini [Italie] ; Gian Maria Fimia [Italie] ; Patrícia Reckziegel [Brésil] ; Soraya Soubhi Smaili [Brésil] ; Claudia Bincoletto [Brésil]Pharmacological Modulators of Autophagy as a Potential Strategy for the Treatment of COVID-19.
000279 (2021) Osama A. Badary [Égypte]Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs.
000326 (2021) C N Prashantha [Inde] ; K. Gouthami [Inde] ; L. Lavanya [Inde] ; Sivaramireddy Bhavanam [Inde] ; Ajay Jakhar [Inde] ; R G Shakthiraju [Inde] ; V. Suraj [Inde] ; K V Sahana [Inde] ; H S Sujana [Inde] ; N M Guruprasad [Inde] ; R. Ramachandra [Inde]Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus.
000332 (2021) R K Hussein [Arabie saoudite] ; H M Elkhair [Arabie saoudite, Soudan]Molecular docking identification for the efficacy of some zinc complexes with chloroquine and hydroxychloroquine against main protease of COVID-19.
000346 (2021) Hardeep Singh Tuli [Inde] ; Shivani Sood ; Jagjit Kaur [Australie] ; Pawan Kumar [Israël] ; Prachi Seth ; Sandeep Punia [Inde] ; Priya Yadav [Inde] ; Anil Kumar Sharma [Inde] ; Diwakar Aggarwal [Inde] ; Katrin Sak [Estonie]Mechanistic insight into anti-COVID-19 drugs: recent trends and advancements.
000347 (2021) Benjamin Coiffard [France] ; Philipp M. Lepper [Allemagne] ; Eloi Prud'Homme [France] ; Florence Daviet [France] ; Nadim Cassir [France] ; Heinrike Wilkens [Allemagne] ; Sami Hraiech [France] ; Frank Langer [Allemagne] ; Pascal A. Thomas [France] ; Martine Reynaud-Gaubert [France] ; Robert Bals [Allemagne] ; Hans-Joachim Sch Fers [Allemagne] ; Laurent Papazian [France] ; Frederik Seiler [Allemagne]Management of lung transplantation in the COVID-19 era-An international survey.
000530 (2021) Wei-Yi Ong [Singapour] ; Mei-Lin Go [Singapour] ; De-Yun Wang [Singapour] ; Irwin Kee-Mun Cheah [Singapour] ; Barry Halliwell [Singapour]Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications.
000556 (2021) Biswa Mohan Sahoo [Inde] ; B V V. Ravi Kumar [Inde] ; J. Sruti [Inde] ; Manoj Kumar Mahapatra [Inde] ; Bimal K. Banik [Arabie saoudite] ; Preetismita Borah [Inde]Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection.
000590 (2021) Maryam Hosseini [États-Unis] ; Wanqiu Chen [États-Unis] ; Daliao Xiao [États-Unis] ; Charles Wang [États-Unis]Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs.
000592 (2021) Hasan Çubuk ; Mehmet Özb LComparison of clinically approved molecules on SARS-CoV-2 drug target proteins: a molecular docking study.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "inhibitors" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "inhibitors" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    inhibitors
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021